Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Kusaba

Showing results (101-110 of 107) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 107 results.
Nature Communications|October 19, 2024
Spatial dynamics of CD39<sup>+</sup>CD8<sup>+</sup> exhausted T cell reveal tertiary lymphoid structures-mediated response to PD-1 blockade in esophageal cancerKenro Tanoue, Hirofumi Ohmura, Koki Uehara, et al.
Cancer Science|August 25, 2018
Epithelial-mesenchymal transition is activated in CD44-positive malignant ascites tumor cells of gastrointestinal cancerMichitaka Nakano, Mamoru Ito, Risa Tanaka, et al.
Journal of Clinical Medicine|November 13, 2021
Does the Use of Peripheral Immune-Related Markers Indicate Whether to Administer Pazopanib, Trabectedin, or Eribulin to Advanced Soft Tissue Sarcoma Patients?Eijiro Shimada, Makoto Endo, Yoshihiro Matsumoto, et al.
Frontiers in Oncology|July 2, 2021
Clinical Impact of Primary Tumor Location in Metastatic Colorectal Cancer Patients Under Later-Line Regorafenib or Trifluridine/Tipiracil TreatmentHiromichi Nakajima, Shota Fukuoka, Toshiki Masuishi, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 6, 2022
Potential therapeutic targets discovery by transcriptome analysis of an in vitro human gastric signet ring carcinoma modelKyoko Yamaguchi, Tomoyasu Yoshihiro, Hiroshi Ariyama, et al.
Frontiers in Oncology|March 25, 2021
Survival Benefit of Crossover Administration of Regorafenib and Trifluridine/Tipiracil Hydrochloride for Patients With Metastatic Colorectal Cancer: Exploratory Analysis of a Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study (REGOTAS)Keigo Chida, Daisuke Kotani, Toshikazu Moriwaki, et al.
BMC Cancer|October 31, 2023
Survival outcomes including salvage therapy of adult head and neck para-meningeal rhabdomyosarcoma: a multicenter retrospective study from JapanKenji Tsuchihashi, Mamoru Ito, Shuji Arita, et al.
Pageof 11

Showing results (101-110 of 107) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
Nature Communications|October 19, 2024
Spatial dynamics of CD39<sup>+</sup>CD8<sup>+</sup> exhausted T cell reveal tertiary lymphoid structures-mediated response to PD-1 blockade in esophageal cancerKenro Tanoue, Hirofumi Ohmura, Koki Uehara, et al.
Cancer Science|August 25, 2018
Epithelial-mesenchymal transition is activated in CD44-positive malignant ascites tumor cells of gastrointestinal cancerMichitaka Nakano, Mamoru Ito, Risa Tanaka, et al.
Journal of Clinical Medicine|November 13, 2021
Does the Use of Peripheral Immune-Related Markers Indicate Whether to Administer Pazopanib, Trabectedin, or Eribulin to Advanced Soft Tissue Sarcoma Patients?Eijiro Shimada, Makoto Endo, Yoshihiro Matsumoto, et al.
Frontiers in Oncology|July 2, 2021
Clinical Impact of Primary Tumor Location in Metastatic Colorectal Cancer Patients Under Later-Line Regorafenib or Trifluridine/Tipiracil TreatmentHiromichi Nakajima, Shota Fukuoka, Toshiki Masuishi, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 6, 2022
Potential therapeutic targets discovery by transcriptome analysis of an in vitro human gastric signet ring carcinoma modelKyoko Yamaguchi, Tomoyasu Yoshihiro, Hiroshi Ariyama, et al.
Frontiers in Oncology|March 25, 2021
Survival Benefit of Crossover Administration of Regorafenib and Trifluridine/Tipiracil Hydrochloride for Patients With Metastatic Colorectal Cancer: Exploratory Analysis of a Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study (REGOTAS)Keigo Chida, Daisuke Kotani, Toshikazu Moriwaki, et al.
BMC Cancer|October 31, 2023
Survival outcomes including salvage therapy of adult head and neck para-meningeal rhabdomyosarcoma: a multicenter retrospective study from JapanKenji Tsuchihashi, Mamoru Ito, Shuji Arita, et al.
Pageof 11